APHA
Back to Annual Meeting Page
 
American Public Health Association
133rd Annual Meeting & Exposition
December 10-14, 2005
Philadelphia, PA
APHA 2005
 
4076.0: Tuesday, December 13, 2005 - Board 5

Abstract #103069

Pharmacological and chemical effects of cigarette additives

Michael David Rabinoff, DO PhD, Deaprtment of Psychiatry, UCLA, 760 Westwood Plaza, Los Angeles, CA 90024-1759, 408-365-5525, mrabinoff@mednet.ucla.edu, Anthony Rissling, BS, Department of Psychology, USC, University Park Campus, Los Angeles, CA 90089, Nicholas. H. Caskey, PhD, Psychology Dept, Dept of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, VA West Los Angeles Healthcare Center, UCLA, Bldg 258 (116B), 11301 Wilshire Boulevard, Los Angeles, CA 90073, and Candice Park, BS, Department of Psychology, UCLA, Aftercare Program, UCLA Medical Plaza Building 300, Los Angeles, CA 90095.

Objective: To investigate the pharmacological and other chemical effects of tobacco additives. Methods: A “snowball” sampling method of the UCSF Legacy Tobacco Documents Library, in conjunction with searching PubMed, the U. of Indiana list of cigarette additives, review of tobacco related and reference textbooks, including the Physicians Desk Reference for Herbal Medicines, and the U.S. Department of Agriculture Dr. Duke Phytochemical Database, the Memorial Sloan Kettering, the U.S. Patent and Trademark and other internet websites. Results: Over 200 of 599 documented cigarette additives were found to have possible pharmacological or chemical effects that could potentially affect human health. Conclusions: While the tobacco industry has stated that many of the additives were added specifically for improving the flavoring and customer acceptance, the data suggests that there may have been other or multiple intended actions of many additives. Our results suggest the possibility that over 200 of 599 documented cigarette additives may have pharmacological actions that can enhance or maintain nicotine delivery, increase the addictiveness of cigarettes, mask or treat symptoms and illnesses associated with smoking behavior, and have chemical effects to camouflage environmental tobacco smoke (ETS) emitted from cigarettes. Whether such uses were intended for all or many of the agents is unknown. The results provide a clear rationale for regulatory control of the use of tobacco additives.

Learning Objectives:

  • At the conclusion of the session, the participant (learner) in this session will

    Keywords: Tobacco, Tobacco Policy

    Presenting author's disclosure statement:

    I wish to disclose that I have NO financial interests or other relationship with the manufactures of commercial products, suppliers of commercial services or commercial supporters.

    Inside Look at Big Tobacco Poster Session

    The 133rd Annual Meeting & Exposition (December 10-14, 2005) of APHA